Top Markets
Coin of the day
Purple Biotech Ltd. Purple Biotech Ltd.

Purple Biotech Ltd.

PPBT
Xếp hạng trong cổ phiếu #40643
Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies... Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies for cancer patients in the United States, specifically addressing challenges like tumor immune evasion and drug resistance. Its diverse oncology pipeline includes CM24, a humanized monoclonal antibody that targets and blocks carcinoembryonic antigen related cell adhesion molecule 1 (CEACAM1). Currently in Phase 2 clinical trials, CM24 is being investigated as a combination therapy with anti-PD-1 checkpoint inhibitors for treating pancreatic ductal adenocarcinoma. Another candidate is NT219, a small molecule compound in Phase 1/2 clinical trials, which functions by inhibiting insulin receptor substrate 1 and 2 (IRS1/2) and signal transducer and activator of transcription (STAT). This compound is being developed for recurrent and/or metastatic squamous cell carcinoma of the head and neck, or colorectal adenocarcinoma. Furthermore, IM1240, a multi-valent antibody designed to activate an anti-tumoral immune response against 5T4-positive tumors, is in its preclinical stage. The company has established significant collaborations, including an agreement with Bristol Myers Squibb Company for Phase 2 clinical trials to assess CM24 in combination with the PD-1 inhibitor nivolumab and chemotherapy, as well as a partnership with Mor Research Applications. Formerly known as Kitov Pharma Ltd., the company adopted the name Purple Biotech Ltd. in December 2020 and is headquartered in Rehovot, Israel.
Giá cổ phiếu
$0.00323826
Đồng bộ lần cuối: 2026-08-12
Vốn hóa thị trường
$104.81K
Thay đổi (1 ngày)
0.00%
Thay đổi (1 năm)
-70.42%
Quốc gia
IL
Giao dịch Purple Biotech Ltd. (PPBT)

Danh mục

Lịch sử giá cổ phiếu của Purple Biotech Ltd. (PPBT)
Giá đóng cửa cao nhất: $0.00 vào 2026-08-01

Giá đóng cửa thấp nhất: $66.99K vào 2002-08-01
Lịch sử giá cổ phiếu của Purple Biotech Ltd. từ 2002 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) 0.00%
2025 -81.67%
2024 -77.97%
2023 -42.38%
2022 -58.58%
2021 -1.91%
2020 -42.76%
2019 -27.25%
2018 -53.94%
2017 -34.07%
2016 -2.83%
2015 -56.33%
2014 -90.72%
2013 19.75%
2012 -27.68%
2011 -56.00%
2010 -33.42%
2009 12.56%
2008 -95.78%
2007 7.52%
2006 9.91%
2005 47.91%
2004 -83.15%
2003 -65.07%
2002 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
$518.36 30.92%
US
$859.40 32.91%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE